Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading under the ticker FLAC, is a blank-check company sponsored by Frazier Life Sciences, a dedicated life sciences investment firm with a long track record in healthcare venture and growth equity. FLAC completed its initial public offering in 2021, targeting acquisition opportunities within the life sciences and biotechnology sector. The company filed an 8-K/A amendment with the SEC on July 25, 2022, under accession number 0001193125-22-200973, reflecting an update to a previously submitted current report. As of that filing date, FLAC remained in active SPAC status pursuing its business combination mandate. For complete filing history, deal timelines, and sponsor background on FLAC, sign up for full data access at SpacDesk.